-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DCC-3116 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DCC-3116 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DCC-3116 in Metastatic Colorectal Cancer Drug Details: DCC-3116 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – B-104 in Osteoporosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.B-104 in Osteoporosis Drug Details:Teriparatide acetate (ZP-PTH) daily formulation is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Bladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Bladder Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Bladder Cancer Drug Details: PD-L1/IDO (IO102/IO103)...
-
Company Profile
Zosano Pharma Corp – Company Profile
Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company. It develops a proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment of a variety of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. Zosano Pharma’s lead product candidate, ADAM Zolmitriptan (M207), is a drug which is used orally and nasally to...
Add to Basket -
Product Insights
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Renal anemia is a disease in which the patient has an unusually low count of red blood cells. Renal is a term that means the kidneys, so anemia is often associated with kidney disease. This type of anemia is caused by a lack of erythropoietin, a protein produced in the kidneys that helps to create red blood cells. Symptoms caused by renal anemia include pale skin and gums, become short of breath, dizziness, and inability to think clearly. The renal...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – desmopressin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry desmopressin Drug Details Desmopressin is under development for the treatment of enuresis. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – influenza [strains A/H1N1 + A/H3N2 + B/Hong Kong] vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry influenza [strains A/H1N1 + A/H3N2 + B/Hong Kong] vaccine Drug Details The vaccine candidate...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – B-104
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry B-104 Drug Details Teriparatide acetate (ZP-PTH) daily formulation is under development for the treatment...
-
Product Insights
Migraine Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Migraine is a disorder characterized by repeated attacks of severe headache. A migraine headache causes throbbing or pulsating pain, usually on only one side of the head. These headaches are often associated with nausea, vomiting, and extreme sensitivity to light and sound. Symptoms include problems speaking, tingling in face, arms, and shoulders, pain behind one of the eyes and pain that gets worse with routine physical activity. The Migraine pipeline drugs market research report provides comprehensive information on the therapeutics...